Next Best Antibiotic for Recurrent Tonsillitis After Augmentin Treatment
Rationale for Clindamycin Selection
- The Infectious Diseases Society of America (IDSA) recommends clindamycin as a strong, high-quality evidence option for treating chronic carriers of Group A Streptococci at a dosage of 20-30 mg/kg/day in 3 doses (maximum 300 mg/dose) for 10 days 1, 2
- Clindamycin has excellent gram-positive coverage, making it particularly effective against Streptococcus pyogenes, the most common bacterial cause of tonsillitis 2
Alternative Options Based on Patient Factors
- For adults with moderate disease who have recently received antibiotics, respiratory fluoroquinolones (gatifloxacin, levofloxacin, moxifloxacin) are particularly effective 3, 4
- Cefdinir is a good alternative with high patient acceptance, especially in cases of non-severe penicillin allergy (e.g., rash) 5
- Combination therapy options include clindamycin plus rifampin 2, 6, high-dose amoxicillin plus rifampin 3, 5, and high-dose amoxicillin plus cefixime 3, 5
Special Considerations
- For beta-lactam allergic patients, clindamycin remains the preferred option, and if contraindicated, macrolides like azithromycin can be considered, though they have lower efficacy rates (77-81% vs. 90-92% for respiratory fluoroquinolones) 4
- For children, high-dose amoxicillin/clavulanate (90 mg/6.4 mg per kg per day) may be tried at a different dosing schedule if the initial treatment failure was potentially due to compliance issues 5, 6
- Rifampin should not be used as monotherapy, should be limited to 10-14 days, and has significant drug interactions due to cytochrome p450 induction 3, 5
Follow-up Recommendations
- Patients should be reassessed after 72 hours of new antibiotic therapy 3, 7
- If symptoms persist despite appropriate second-line therapy, consider further evaluation with cultures 3, possible chronic carrier state rather than true infection 1, 2, and potential need for tonsillectomy in cases of truly recurrent tonsillitis 2